Terms: = Pancreatic cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Treatment
54 results:
1. Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases.
Karim S; Seidensticker R; Seidensticker M; Ricke J; Schinner R; Treitl K; Rübenthaler J; Ingenerf M; Schmid-Tannwald C
Radiol Oncol; 2024 Mar; 58(1):33-42. PubMed ID: 38378033
[TBL] [Abstract] [Full Text] [Related]
2. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to treatment.
Overbeek KA; Poulsen JL; Lanzillotta M; Vinge-Holmquist O; Macinga P; Demirci AF; Sindhunata DP; Backhus J; Algül H; Buijs J; Levy P; Kiriukova M; Goni E; Hollenbach M; Miksch RC; Kunovsky L; Vujasinovic M; Nikolic S; Dickerson L; Hirth M; Neurath MF; Zumblick M; Vila J; Jalal M; Beyer G; Frost F; Carrara S; Kala Z; Jabandziev P; Sisman G; Akyuz F; Capurso G; Falconi M; Arlt A; Vleggaar FP; Barresi L; Greenhalf B; Czakó L; Hegyi P; Hopper A; Nayar MK; Gress TM; Vitali F; Schneider A; Halloran CM; Trna J; Okhlobystin AV; Dagna L; Cahen DL; Bordin D; Rebours V; Mayerle J; Kahraman A; Rasch S; Culver E; Kleger A; Martínez-Moneo E; Røkke O; Hucl T; Olesen SS; Bruno MJ; Della-Torre E; Beuers U; Löhr JM; Rosendahl J;
Clin Gastroenterol Hepatol; 2024 May; 22(5):994-1004.e10. PubMed ID: 38184096
[TBL] [Abstract] [Full Text] [Related]
3. A systematic review meta-analysis and meta-regression on the implications of an aberrant right hepatic artery in patients undergoing pancreaticoduodenectomy for the treatment of malignant disease.
Chorti A; Bontinis V; Bontinis A; Alifieris CE; Chatziantoniou G; Karlafti E; Michalopoulos A; Paramythiotis D
Minerva Surg; 2024 Feb; 79(1):82-91. PubMed ID: 37955856
[TBL] [Abstract] [Full Text] [Related]
4. Impact of primary tumor resection and metastasectomy among gastroentero-pancreatic neuroendocrine tumors with liver metastases only on survival.
Chen Q; Li K; Rhodin KE; Bartholomew AJ; Lidsky ME; Wei Q; Cai J; Luo S; Zhao H
HPB (Oxford); 2024 Jan; 26(1):125-136. PubMed ID: 37806829
[TBL] [Abstract] [Full Text] [Related]
5. NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial.
Wainberg ZA; Melisi D; Macarulla T; Pazo Cid R; Chandana SR; De La Fouchardière C; Dean A; Kiss I; Lee WJ; Goetze TO; Van Cutsem E; Paulson AS; Bekaii-Saab T; Pant S; Hubner RA; Xiao Z; Chen H; Benzaghou F; O'Reilly EM
Lancet; 2023 Oct; 402(10409):1272-1281. PubMed ID: 37708904
[TBL] [Abstract] [Full Text] [Related]
6. Solasodine suppresses the metastasis of gastric cancer through claudin-2 via the AMPK/STAT3/NF-κB pathway.
Su K; Yao X; Guo C; Qian C; Wang Y; Ma X; Wang X; Yang Y
Chem Biol Interact; 2023 Jul; 379():110520. PubMed ID: 37121296
[TBL] [Abstract] [Full Text] [Related]
7. Deubiquitinating enzyme Josephin-2 stabilizes PHGDH to promote a cancer stem cell phenotype in hepatocellular carcinoma.
Wang Y; Li ZX; Wang JG; Li LH; Shen WL; Dang XW
Genes Genomics; 2023 Feb; 45(2):215-224. PubMed ID: 36583817
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive transcriptomic profiling and mutational landscape of primary gastric linitis plastica.
Liu Z; Hong LL; Zheng JS; Ling ZN; Zhang ZL; Qi YN; Zhang XY; Zhu TY; Wang JL; Han J; Chen XL; Yu QM; Wang S; Li P; Ling ZQ
Gastric Cancer; 2023 Mar; 26(2):203-219. PubMed ID: 36450891
[TBL] [Abstract] [Full Text] [Related]
9. Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma.
Xiao Y; Zhang B; Cloyd JM; Xu G; Du S; Mao Y; Pawlik TM
Surg Oncol; 2022 Sep; 44():101849. PubMed ID: 36116415
[TBL] [Abstract] [Full Text] [Related]
10. Terpinen-4-ol inhibits the proliferation and mobility of pancreatic cancer cells by downregulating Rho-associated coiled-coil containing protein kinase 2.
Cao W; Tian R; Pan R; Sun B; Xiao C; Chen Y; Zeng Z; Lei S
Bioengineered; 2022 Apr; 13(4):8643-8656. PubMed ID: 35322742
[TBL] [Abstract] [Full Text] [Related]
11. HNRNPC regulates rhoa to induce DNA damage repair and cancer-associated fibroblast activation causing radiation resistance in pancreatic cancer.
Xia N; Yang N; Shan Q; Wang Z; Liu X; Chen Y; Lu J; Huang W; Wang Z
J Cell Mol Med; 2022 Apr; 26(8):2322-2336. PubMed ID: 35277915
[TBL] [Abstract] [Full Text] [Related]
12. A nationwide analysis of pancreatic cancer trial enrollment reveals disparities and participation problems.
Hue JJ; Katayama ES; Markt SC; Elshami M; Saltzman J; Bajor D; Hosmer A; Mok S; Dumot J; Ammori JB; Rothermel LD; Hardacre JM; Winter JM; Ocuin LM
Surgery; 2022 Jul; 172(1):257-264. PubMed ID: 34839935
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of factors predicting loss of benefit provided by laparoscopic distal pancreatectomy compared to open approach.
Partelli S; Cinelli L; Andreasi V; Rancoita PMV; Pecorelli N; Tamburrino D; Crippa S; Falconi M
Updates Surg; 2022 Feb; 74(1):213-221. PubMed ID: 34687429
[TBL] [Abstract] [Full Text] [Related]
14. Patterns of Metastatic Disease in Patients with cancer Derived from Natural Language Processing of Structured CT Radiology Reports over a 10-year Period.
Do RKG; Lupton K; Causa Andrieu PI; Luthra A; Taya M; Batch K; Nguyen H; Rahurkar P; Gazit L; Nicholas K; Fong CJ; Gangai N; Schultz N; Zulkernine F; Sevilimedu V; Juluru K; Simpson A; Hricak H
Radiology; 2021 Oct; 301(1):115-122. PubMed ID: 34342503
[TBL] [Abstract] [Full Text] [Related]
15. Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Qin S; Li Q; Gu S; Chen X; Lin L; Wang Z; Xu A; Chen X; Zhou C; Ren Z; Yang L; Xu L; Bai Y; Chen L; Li J; Pan H; Cao B; Fang W; Wu W; Wang G; Cheng Y; Yu Z; Zhu X; Jiang D; Lu Y; Wang H; Xu J; Bai L; Liu Y; Lin H; Wu C; Zhang Y; Yan P; Jin C; Zou J
Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):559-568. PubMed ID: 33971141
[TBL] [Abstract] [Full Text] [Related]
16. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
Li T; Guo T; Liu H; Jiang H; Wang Y
Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
[TBL] [Abstract] [Full Text] [Related]
17. RET isoforms contribute differentially to invasive processes in pancreatic ductal adenocarcinoma.
Lian EY; Hyndman BD; Moodley S; Maritan SM; Mulligan LM
Oncogene; 2020 Oct; 39(41):6493-6510. PubMed ID: 32884116
[TBL] [Abstract] [Full Text] [Related]
18. Colorectal cancer (CRC) as a multifactorial disease and its causal correlations with multiple signaling pathways.
Wan ML; Wang Y; Zeng Z; Deng B; Zhu BS; Cao T; Li YK; Xiao J; Han Q; Wu Q
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32149326
[TBL] [Abstract] [Full Text] [Related]
19. A prognostic Bayesian network that makes personalized predictions of poor prognostic outcome post resection of pancreatic ductal adenocarcinoma.
Bradley A; Van der Meer R; McKay CJ
PLoS One; 2019; 14(9):e0222270. PubMed ID: 31498836
[TBL] [Abstract] [Full Text] [Related]
20. New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation.
Tan JL; Li F; Yeo JZ; Yong KJ; Bassal MA; Ng GH; Lee MY; Leong CY; Tan HK; Wu CS; Liu BH; Chan TH; Tan ZH; Chan YS; Wang S; Lim ZH; Toh TB; Hooi L; Low KN; Ma S; Kong NR; Stein AJ; Wu Y; Thangavelu MT; Suzuki A; Periyasamy G; Asara JM; Dan YY; Bonney GK; Chow EK; Lu GD; Ng HH; Kanagasundaram Y; Ng SB; Tam WL; Tenen DG; Chai L
Gastroenterology; 2019 Dec; 157(6):1615-1629.e17. PubMed ID: 31446059
[TBL] [Abstract] [Full Text] [Related]
[Next]
